Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001437749-25-011856
Filing Date
2025-04-14
Accepted
2025-04-14 09:20:12
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-14

Document Format Files

Seq Description Document Type Size
1 ARS arssava.pdf ARS 1704715
  Complete submission text file 0001437749-25-011856.txt   2349526
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41905 | Film No.: 25834356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)